Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3.

Autor: Campbell RA; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and., Schwertz H; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and.; Rocky Mountain Center for Occupational and Environmental Health, University of Utah, Salt Lake City, UT., Hottz ED; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Instituto Nacional de Infectologia Evandro Chagas and.; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Rowley JW; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and., Manne BK; University of Utah Molecular Medicine Program, Salt Lake City, UT., Washington AV; Department of Biology, University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico.; Department of Internal Medicine, Universidad Central del Caribe, Bayamón, Puerto Rico., Hunter-Mellado R; Department of Biology, University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico.; Department of Internal Medicine, Universidad Central del Caribe, Bayamón, Puerto Rico., Tolley ND; University of Utah Molecular Medicine Program, Salt Lake City, UT., Christensen M; Department of Internal Medicine and., Eustes AS; University of Utah Molecular Medicine Program, Salt Lake City, UT., Montenont E; University of Utah Molecular Medicine Program, Salt Lake City, UT., Bhatlekar S; University of Utah Molecular Medicine Program, Salt Lake City, UT., Ventrone CH; Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT., Kirkpatrick BD; Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT., Pierce KK; Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT., Whitehead SS; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Diehl SA; Vaccine Testing Center, Department of Microbiology and Molecular Genetics, University of Vermont Larner College of Medicine, Burlington, VT., Bray PF; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and., Zimmerman GA; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and., Kosaka Y; University of Utah Molecular Medicine Program, Salt Lake City, UT., Bozza PT; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil., Bozza FA; Instituto Nacional de Infectologia Evandro Chagas and.; Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, Brazil; and., Weyrich AS; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and., Rondina MT; University of Utah Molecular Medicine Program, Salt Lake City, UT.; Department of Internal Medicine and.; Department of Internal Medicine, George E. Wahlen Veterans Affairs Medical Center and Geriatric Research, Education, and Clinical Center, Salt Lake City, UT.

Publikováno v: Blood [Blood] 2019 May 09; Vol. 133 (19), pp. 2013-2026. Date of Electronic Publication: 2019 Feb 05.